RMTI Earnings & Financial Statements
Rockwell Medical, Inc.
$7.66
-$0.19(-2.42%)
50
Overall
60
Value
45
Tech
47
Quality
Market Cap
$30.87M
Volume
15.56K
52W Range
$4.89 - $12.90
Target Price
$20.00
RMTI earnings and financial statements: Rockwell Medical, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
RMTI Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $69.26M | $101.49M | $83.61M | $72.81M | $61.93M |
| Cost of revenue | $57.56M | $84.00M | $74.91M | $68.73M | $64.35M |
| Operating income | -$4.69M | $608.0K | -$6.67M | -$16.78M | -$30.34M |
| EBITDA | -$1.71M | $3.37M | -$1.58M | -$16.17M | -$27.80M |
| Net income | -$5.31M | -$480.0K | -$8.44M | -$18.68M | -$32.67M |
| EPS (diluted) | $-0.15 | $-0.30 | $-3.70 | $-18.90 | $-38.50 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $57.15M | $59.21M | $52.17M | $46.63M | $48.57M |
| Total liabilities | $20.16M | $26.62M | $30.88M | $32.53M | $46.04M |
| Shareholders’ equity | $37.00M | $32.59M | $21.29M | $14.11M | $2.54M |
| Cash and equivalents | $10.71M | $15.66M | $8.98M | $10.10M | $13.28M |
| Long-term debt | $10.58M | $11.10M | $11.26M | $12.22M | $13.19M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$700.0K | $4.20M | -$9.41M | -$16.93M | -$33.53M |
| Capital expenditure | -$542.0K | -$1.01M | -$284.0K | -$281.0K | -$522.0K |
| Free cash flow | -$1.24M | $3.19M | -$9.70M | -$17.21M | -$34.06M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RMTI | $7.66 | -2.4% | 15.56K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |